← Leaderboards
Carolyn Y Muller
University Of Texas Sw Med Ctr/Dallas
$16,478,837
Attributed
$20,220,977
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,220,977 · 3
By mechanism
UG1$19,227,026 · 1
M01$642,969 · 1
P30$350,982 · 1
Top collaborators
- Olivier Rixe2 shared
- Melanie E Royce2 shared
- Ursa Brown Glaberman1 shared
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Madhukar H Trivedi$36,286,053
- Craig R. Malloy$13,817,010
- Roger Rosenberg$8,764,462
- Ralph Victor Shohet$20,048,453
- Fiemu E Nwariaku$2,692,898
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCatchment AreaScreeningSiteMexicanCancer CarePhysiciansProgramsPatternUniversitiesPreventionNew MexicoCare DeliveryCommunity Clinical Oncology ProgramCommunitiesClinical TrialsCancer Health DisparityCancer PatientPovertyNot Hispanic Or LatinoUnderserved PopulationClinical Trials NetworkCollaborationsAmerican Indians
Grant awards (18)
The NCI Community Oncology Research Program: The New Mexico NCORP$1,589,898
UG1 · FY2025 · CA · contact PI
Clinical Protocol and Data Management$175,491
P30 · FY2025 · CA · contact PI
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites$1,586,915
UG1 · FY2024 · CA · contact PI
Clinical Protocol and Data Management$175,491
P30 · FY2024 · CA · contact PI
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites$1,588,186
UG1 · FY2023 · CA · contact PI
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites$1,668,973
UG1 · FY2022 · CA · contact PI
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites$1,651,700
UG1 · FY2021 · CA · contact PI
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites$1,767,135
UG1 · FY2020 · CA · contact PI
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites$1,767,175
UG1 · FY2019 · CA · contact PI
NCI Community Oncology Research Program Minority Underserved Community Sites$1,791,736
UG1 · FY2018 · CA · contact PI
NCI Community Oncology Research Program Minority Underserved Community Sites$1,648,482
UG1 · FY2017 · CA · contact PI
NCI Community Oncology Research Program Minority Underserved Community Sites$1,399,676
UG1 · FY2016 · CA · contact PI
NCI Community Oncology Research Program Minority Underserved Community Sites$1,383,575
UG1 · FY2015 · CA
NCI Community Oncology Research Program Minority Underserved Community Sites$1,383,575
UG1 · FY2014 · CA
Phase I Trial of Intraperitoneal Adenoviral p53 Gene Therapy in Ovarian Cancer$221
M01 · FY2004 · RR
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER$321,374
M01 · FY2002 · RR
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER$321,374
M01 · FY2001 · RR
INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER$0
M01 · FY2000 · RR